Success Metrics

Clinical Success Rate
93.1%

Based on 108 completed trials

Completion Rate
93%(108/116)
Active Trials
19(12%)
Results Posted
52%(56 trials)
Terminated
8(5%)

Phase Distribution

Ph phase_4
9
6%
Ph phase_2
39
25%
Ph phase_3
36
24%
Ph early_phase_1
1
1%
Ph phase_1
37
24%
Ph not_applicable
31
20%

Phase Distribution

38

Early Stage

39

Mid Stage

45

Late Stage

Phase Distribution153 total trials
Early Phase 1First-in-human
1(0.7%)
Phase 1Safety & dosage
37(24.2%)
Phase 2Efficacy & side effects
39(25.5%)
Phase 3Large-scale testing
36(23.5%)
Phase 4Post-market surveillance
9(5.9%)
N/ANon-phased studies
31(20.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.5%

108 of 118 finished

Non-Completion Rate

8.5%

10 ended early

Currently Active

19

trials recruiting

Total Trials

153

all time

Status Distribution
Active(22)
Completed(108)
Terminated(10)
Other(13)

Detailed Status

Completed108
unknown13
Recruiting12
Terminated8
Active, not recruiting7
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
153
Active
19
Success Rate
93.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.7%)
Phase 137 (24.2%)
Phase 239 (25.5%)
Phase 336 (23.5%)
Phase 49 (5.9%)
N/A31 (20.3%)

Trials by Status

terminated85%
unknown138%
withdrawn21%
active_not_recruiting75%
completed10871%
not_yet_recruiting32%
recruiting128%

Recent Activity

Clinical Trials (153)

Showing 20 of 153 trialsScroll for more
NCT07736495Phase 2

Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis

Recruiting
NCT06141473Phase 3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Active Not Recruiting
NCT02162849Phase 4

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

Active Not Recruiting
NCT05781399Phase 1

First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Completed
NCT07695285Phase 2

Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial

Not Yet Recruiting
NCT03298802Phase 3

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Terminated
NCT05714085Phase 2

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Recruiting
NCT07695779Phase 1

QT Interval Effects Study of Oral FXS5626 Tablets

Not Yet Recruiting
NCT06852469Phase 4

Computational Assessment of GABA Receptor Modulation in PTSD

Recruiting
NCT06762964Phase 2

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

Recruiting
NCT07300189Phase 1

A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

Recruiting
NCT03941808Not Applicable

Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.

Completed
NCT00856947Phase 1

Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood

Active Not Recruiting
NCT06366464Phase 3

A Study of Pitolisant in Patients With Prader-Willi Syndrome

Recruiting
NCT05658575Phase 2

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Recruiting
NCT06727396Phase 1

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

Completed
NCT05259046Not Applicable

The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health

Active Not Recruiting
NCT04804241Phase 2

Senicapoc in Alzheimer's Disease

Recruiting
NCT07314242Phase 2

A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD

Not Yet Recruiting
NCT05822544Phase 1

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
153